tradmap

SRXH Earnings SRx Health Solutions, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$59 -$29 $0 $0 2015 2016 2017 2020 2021 2022 2023 2024 2024 2025
EPS
Revenue (annual)
$0 $27M $55M 2018 2018 2019 2020 2021 2022 2023 2024 2024 2025
Revenue
Net income (annual)
-$184M -$91M $3M $0 2018 2018 2019 2020 2021 2022 2023 2024 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$45 -$1 $43 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
-$35M $4M $43M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$32M -$16M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–60 of 60
Q3 20262026-06-30-0.362026-08-1310-Q
Q2 20262026-03-31-0.022026-05-1410-Q
Q1 20262025-12-31-0.262026-02-1310-Q
Q4 2025 (derived)2025-09-3042.942025-12-0510-K
FY 20252025-09-30-2.132025-12-0510-K
Q3 20252025-06-30-44.512025-09-3010-Q
Q1 20252025-03-31-0.392025-05-1510-Q
Q1 20252024-12-31-0.17——
FY 20242024-12-31-0.102025-03-3110-K
Q3 20242024-09-300.732024-11-1410-Q
FY 20242024-09-30-1.95——
Q2 20242024-06-30-0.142024-08-1410-Q
Q1 20242024-03-31-3.602024-05-1710-Q
Q4 2023 (derived)2023-12-31-20.692024-04-1210-K
FY 20232023-12-31-32.292024-04-1210-K
Q3 20232023-09-30-2.302023-11-1410-Q
Q2 20232023-06-30-4.272023-08-2110-Q
Q1 20232023-03-31-5.032023-05-1210-Q
Q4 2022 (derived)2022-12-31-58.422023-03-2810-K
FY 20222022-12-31-58.932023-03-2810-K
Q3 20222022-09-30-0.222022-11-1010-Q
Q2 20222022-06-30-0.152022-08-1110-Q
Q1 20222022-03-31-0.142022-05-1210-Q
Q4 2021 (derived)2021-12-310.452022-03-2910-K
FY 20212021-12-310.142022-03-2910-K
Q3 20212021-09-30-0.122021-11-1010-Q
Q2 20212021-06-301.192021-08-1210-Q
Q1 20212021-03-31-1.38——
FY 20202020-12-31-7.26——
Q3 20202020-09-30-0.21——
Q2 20202020-06-30-2.26——
Q2 20192019-02-28-0.092019-04-1510-Q
Q1 20192018-11-300.002019-01-1410-Q
Q2 20182018-02-28-0.312018-04-1610-Q
Q1 20182017-11-300.002018-01-1810-Q
Q4 2017 (derived)2017-08-310.002017-11-2910-K
FY 20172017-08-31-0.022017-11-2910-K
Q3 20172017-05-31-0.012017-07-1410-Q
Q2 20172017-02-28-0.012017-04-1210-Q
Q1 20172016-11-300.002017-01-1210-Q
Q4 2016 (derived)2016-08-31-0.012016-12-0510-K
FY 20162016-08-31-0.012016-12-0510-K
Q3 20162016-05-31-0.002016-07-1510-Q
Q2 20162016-02-290.002016-04-1210-Q
Q1 20162015-11-300.002016-01-2910-Q
Q4 2015 (derived)2015-08-310.002015-11-1810-K
FY 20152015-08-310.002015-11-1810-K
Q3 20152015-05-310.002015-07-2010-Q
Q2 20152015-02-280.002015-04-1410-Q
Q1 20152014-11-300.002015-01-1410-Q
Q4 2014 (derived)2014-08-310.092014-12-0410-K
FY 20142014-08-310.002014-12-0410-K
Q3 20142014-05-310.002014-07-1510-Q
Q2 20142014-02-280.002014-04-1410-Q
Q1 20142013-11-30-0.092014-01-1410-Q
Q4 2013 (derived)2013-08-31-1.252013-11-2610-K
FY 20132013-08-31-1.562013-11-2610-K
Q3 20132013-05-31-0.122013-07-1510-Q
Q2 20132013-02-28-0.102013-04-1510-Q
Q1 20132012-11-30-0.092013-01-2210-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.